Demographics and risk factors for pediatric recurrent acute pancreatitis

Cheryl E Gariepy1, Chee Y Ooi2, Asim Maqbool3

  • 1Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio, USA.

Insights

Recurrent acute pancreatitis (RAP) in children is a significant concern, often leading to chronic disease. Identifying risk factors is crucial for developing effective treatments to prevent further episodes and complications.

Area of Science:

  • Pediatric Gastroenterology
  • Pancreatology
  • Autoimmune Disorders

Background:

  • Recurrent acute pancreatitis (RAP) affects 20-30% of children after an initial episode.
  • Progression to chronic pancreatitis can occur over time.
  • Identifying risk factors is key for therapeutic interventions.

Purpose of the Study:

  • To review recent findings on risk factors and disease progression in pediatric recurrent acute pancreatitis.
  • To highlight the impact of various conditions on pancreatitis risk in children.

Main Methods:

  • Literature review of recent studies on pediatric pancreatitis.
  • Analysis of risk factors including obesity, cystic fibrosis, Crohn disease, and ulcerative colitis.

Main Results:

  • Obesity is linked to increased biliary stone disease and severe acute pancreatitis.
  • Cystic fibrosis and CFTR-related disorders can present as RAP.
  • Children with Crohn disease have a higher risk of acute pancreatitis; ulcerative colitis is associated with pediatric autoimmune pancreatitis.

Conclusions:

  • Pediatric RAP is a painful condition causing gland destruction and insufficiency.
  • Risk factors are increasingly understood, but preventive treatments are still needed.
Abstract

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
352
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
754
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
360
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
151
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48